-
Loading metrics
Concerns for efficacy of a 30-valent M-protein-based Streptococcus pyogenes vaccine in regions with high rates of rheumatic heart disease
- Philip M. Giffard,
- Steven Y. C. Tong,
- Deborah C. Holt,
- Anna P. Ralph,
- Bart J. Currie
x
-
- Published: July 3, 2019
- https://doi.org/10.1371/journal.pntd.0007511